{"database": "lobbying", "table": "lobbying_activities", "rows": [[2468585, "7d989835-62aa-4d8a-bf8f-84be3cfaaa5a", "Q2", "KOUNTOUPES DENHAM CARR & REID, LLC", 320918, "GLENMARK PHARMACEUTICALS, INC., USA", 2020, "second_quarter", "PHA", "General information about the company and the industry.  Issues related to affordability and pricing of pharmaceuticals.  Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics.  H.R. 6800, the HEROES Act. \nIssues related to the federal response to the COVID-19 pandemic.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2020-07-16T13:19:31.067000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2468585"], "units": {}, "query_ms": 25.73209593538195, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}